Altoida, Inc., a trailblazer in AI- and augmented reality (AR)-based digital diagnostics for neurological conditions, has announced the appointment of three globally recognized experts to its Clinical and Scientific Advisory Board. The new members — Dr. Mona Flores, former Global…
TestGorilla, the leading talent discovery platform known for its skills-based hiring solutions, has announced the launch of its AI-powered video interviews, designed to replace traditional manual screening calls. The new feature introduces a structured, science-backed approach to assessing candidates’ skills…
Trilliant Health, a leading analytics and market research firm specializing in healthcare economics, has released its 2025 Trends Shaping the Health Economy Report, offering a comprehensive analysis of six major forces that are expected to define the direction and challenges…
Masimo (NASDAQ: MASI) announced compelling new findings from an exploratory analysis of its Investigation of Skin Pigmentation Effect on Performance of Pulse Oximetry (INSPIRE) feasibility study, published in CHEST Critical Care. Led by Dr. Andrew Goodwin and colleagues at the…
IonQ, Inc., a global leader in quantum computing, has announced the successful completion of its acquisition of Vector Atomic, a California-based pioneer in quantum sensing technology. The all-stock transaction marks a major milestone in IonQ’s evolution toward becoming a fully…
Veristat, a global clinical research organization (CRO) and consultancy specializing in complex clinical studies, announced its participation in the upcoming Clinical Outsourcing Group (COG) – Bay Area 2025 conference, to be held October 21–22, 2025, at the Hyatt Regency San…
AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing proprietary nebulized combination therapies for chronic respiratory diseases, announced the successful closing of a $21 million Series A financing. The funding round was led by Avalon BioVentures, with additional participation…
Alloy Therapeutics Inc., a biotechnology ecosystem company focused on democratizing access to advanced drug discovery technologies, has announced a strategic collaboration with the University of British Columbia (UBC). This partnership aims to accelerate the discovery and development of novel antibody…
Bayer AG and its wholly owned, independently operated subsidiary BlueRock Therapeutics LP, a clinical-stage cell therapy company, have announced encouraging 36-month follow-up data from exPDite, a Phase I clinical trial investigating bemdaneprocel, an investigational stem cell-derived therapy designed to treat…
MaaT Pharma, a clinical-stage biotechnology company pioneering Microbiome Ecosystem Therapies™ (MET) to improve survival outcomes in patients with cancer through immune modulation, today announced the successful completion of the second pre-planned safety interim analysis of its ongoing Phase 2b PHOEBUS…